>Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer.
>
>The team used next generation sequencing to identify types of genetic regulators called small RNAs that were different during the course of bone cancer progression.
>
>The breakthrough drug increases survival rates by 50 per cent without the need for surgery or chemotherapy. And unlike chemotherapy, it doesn't cause toxic side effects like hair loss, tiredness and sickness.